Prudential Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Sell |
22,808
-6,605
| -22% | -$623K | ﹤0.01% | 1352 |
|
|
2025
Q1 | $3.43M | Buy |
29,413
+26,740
| +1,000% | +$3.12M | ﹤0.01% | 1022 |
|
|
2024
Q4 | $249K | Sell |
2,673
-27
| -1% | -$2.52K | ﹤0.01% | 2039 |
|
|
2024
Q3 | $243K | Sell |
2,700
-180
| -6% | -$16.2K | ﹤0.01% | 2463 |
|
|
2024
Q2 | $232K | Buy |
2,880
+117
| +4% | +$9.42K | ﹤0.01% | 2441 |
|
|
2024
Q1 | $220K | Buy |
2,763
+38
| +1% | +$3.03K | ﹤0.01% | 2442 |
|
|
2023
Q4 | $217K | Buy |
+2,725
| New | +$217K | ﹤0.01% | 2417 |
|
|
2020
Q4 | – | Sell |
-7,545
| Closed | -$538K | – | 2447 |
|
|
2020
Q3 | $538K | Sell |
7,545
-14,667
| -66% | -$1.05M | ﹤0.01% | 1923 |
|
|
2020
Q2 | $1.83M | Buy |
+22,212
| New | +$1.83M | ﹤0.01% | 1378 |
|
|
2020
Q1 | – | Sell |
-2,520
| Closed | -$260K | – | 2354 |
|
|
2019
Q4 | $260K | Buy |
+2,520
| New | +$260K | ﹤0.01% | 2256 |
|